Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tadalafil and bergapten mitigate streptozotocin-induced sporadic Alzheimer's disease in mice via modulating neuroinflammation, PI3K/Akt, Wnt/β-catenin, AMPK/mTOR signaling pathways
Mohamed A. Salem, Barbara Budzyńska, Joanna Kowalczyk, et al.
Toxicology and Applied Pharmacology (2021) Vol. 429, pp. 115697-115697
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Gastrodin regulates the TLR4/TRAF6/NF-κB pathway to reduce neuroinflammation and microglial activation in an AD model
Wensheng Wang, Yu Wang, Fengjie Wang, et al.
Phytomedicine (2024) Vol. 128, pp. 155518-155518
Closed Access | Times Cited: 20
Neurotrophins and Other Growth Factors in the Pathogenesis of Alzheimer’s Disease
Tadahiro Numakawa, Ryutaro Kajihara
Life (2023) Vol. 13, Iss. 3, pp. 647-647
Open Access | Times Cited: 31
Natural polyphenol: Their pathogenesis-targeting therapeutic potential in Alzheimer's disease
Chengu Niu, Miaoxian Dong, Yingcai Niu
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116359-116359
Closed Access | Times Cited: 8
Brain insulin resistance mediated cognitive impairment and neurodegeneration: Type-3 diabetes or Alzheimer’s Disease
Abhilasha Ahlawat, Vaibhav Walia, Munish Garg
Acta Neurologica Belgica (2025)
Closed Access | Times Cited: 1
Antiplatelet Therapy as a Novel Approach in Parkinson's Disease: Repositioning Ticagrelor to Alleviate Rotenone-Induced Parkinsonism via Modulation of ER Stress, Apoptosis, and Autophagy
Muhammad Muneeb, Dalaal M. Abdallah, Hanan S. El‐Abhar, et al.
Neuropharmacology (2025) Vol. 269, pp. 110346-110346
Closed Access | Times Cited: 1
Inhibition of VDAC1 Rescues Aβ1-42-Induced Mitochondrial Dysfunction and Ferroptosis via Activation of AMPK and Wnt/β-Catenin Pathways
Xinpei Zhou, Ximin Tang, Tao Li, et al.
Mediators of Inflammation (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 20
Targeting autophagy in Alzheimer’s disease: Animal models and mechanisms
Xiaowen Zhang, Xiangxing Zhu, Dongsheng Tang, et al.
动物学研究 (2023) Vol. 44, Iss. 6, pp. 1132-1145
Open Access | Times Cited: 19
Emerging phosphodiesterase inhibitors for treatment of neurodegenerative diseases
Yu Xiang, Swapna Naik, Liyun Zhao, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 4, pp. 1404-1445
Closed Access | Times Cited: 7
Oxyresveratrol Improves Cognitive Impairments and Episodic-like Memory through Modulating Neuroinflammation and PI3K-Akt Signaling Pathway in LPS-Induced Mice
Guangling Yin, Chunxing Pan, Hong Liu, et al.
Molecules (2024) Vol. 29, Iss. 6, pp. 1272-1272
Open Access | Times Cited: 6
From attention-deficit hyperactivity disorder to sporadic Alzheimer’s disease—Wnt/mTOR pathways hypothesis
Edna Grünblatt, Jan Homolak, Ana Babić Perhoč, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 15
The Interplay between cGMP and Calcium Signaling in Alzheimer’s Disease
Aileen Jehle, Olga Garaschuk
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7048-7048
Open Access | Times Cited: 19
Unlocking Hope: Therapeutic Advances and Approaches in Modulating the Wnt Pathway for Neurodegenerative Diseases
Navid Faraji, Negar Ebadpour, Mohammad Abavisani, et al.
Molecular Neurobiology (2024)
Open Access | Times Cited: 4
Drugs repurposing in the experimental models of Alzheimer’s disease
Sheer A. Joodi, Weam W. Ibrahim, Mahmoud M. Khattab
Inflammopharmacology (2025)
Open Access
Cationic lipid based Nanoparticles-Formulated Artesunate as a Neurotherapeutic Agent in Alzheimer's Disease: Targeting Inflammasome Activation and Pyroptosis Pathway
Reem T. Attia, Sherif Ashraf Fahmy, Raghda T. Abdel‐Latif, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106803-106803
Closed Access
Rapamycin mitigates neurotoxicity of fluoride and aluminum by activating autophagy through the AMPK/mTOR/ULK1 pathway in hippocampal neurons and NG108-15 cells
Dan Tao, Ya Xia, Qilong Liao, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Naturally occurring coumarins and derivatives may have potential for the treatment of Alzheimer's disease
Ibukun O. Oresanya, Nurten Abaci Kaplan, İlkay Erdoğan Orhan
Elsevier eBooks (2025), pp. 163-191
Closed Access
Exploring the role of interleukin-27 as a regulator of neuronal survival in central nervous system diseases
AbigailS Hackam, AndreaN Nortey, KimberlyN Garces
Neural Regeneration Research (2022) Vol. 17, Iss. 10, pp. 2149-2149
Open Access | Times Cited: 17
Molecular interplay between phytoconstituents of Ficus Racemosa and neurodegenerative diseases
Anu Rani, Zia Ul Sabah, Fauzia Tabassum, et al.
European Journal of Neuroscience (2024) Vol. 59, Iss. 7, pp. 1833-1847
Closed Access | Times Cited: 3
How do phosphodiesterase-5 inhibitors affect cancer? A focus on glioblastoma multiforme
Mehdi Sanati, Samaneh Aminyavari, Hamid Mollazadeh, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 2, pp. 323-339
Closed Access | Times Cited: 14
Roles of traditional chinese medicine regulating neuroendocrinology on AD treatment
Chujun Deng, Huize Chen, Zeyu Meng, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 13
Bergapten attenuates hemorrhagic shock induced multi-organ injury by inhibiting NLRP3 inflammasome activation and pyroptosis
Taiwen Rao, Wei Yang, Ximei Ma, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112839-112839
Closed Access | Times Cited: 2
Breaking Barriers in Alzheimer’s Disease: the Role of Advanced Drug Delivery Systems
Devank Shekho, Ritika Mishra, Raj Kamal, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 7
Closed Access | Times Cited: 2
Polypharmacological Potential of Phosphodiesterase 5 Inhibitors for the Treatment of Neurocognitive Disorders
Ashish Kumar, Fred Kim, Dong‐Keun Song, et al.
Aging and Disease (2024)
Open Access | Times Cited: 1
Multimodal action of phosphodiesterase 5 inhibitors against neurodegenerative disorders: An update review
Niraj Kumar Singh, Pranjul Singh, Prachi Varshney, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 11
Closed Access | Times Cited: 1
Insulin and liraglutide attenuate brain pathology in diabetic mice by enhancing the Wnt/β‑catenin signaling pathway
Yuan Zhao, Jie Yu, Fan Ping, et al.
Experimental and Therapeutic Medicine (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top